Day: February 9, 2012

HCV/HIV Drug Safety Communication – Drug Interactions

Link to Official FDA Alert         [Posted 02/09/2012]Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication – Drug InteractionsAUDIENCE: Infectious Disease, PharmacyISSUE: FDA notified healthcare professionals and patients that drug interactions between the hepatitis C virus (HCV) protease inhibitor Victrelis (boceprevir) and certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors […]